SGMS1促进MSC的骨质分化,并通过调节Cer/PP2A/Akt通路来加强骨质生成-血管生成合
Kai Yang1, Ying-Yi Luan2, Shan Wang3
1Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital, Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, China.
iScience
|March 28, 2024
概括
SGMS1增强了介质干细胞 (MSC) 的骨质分化和骨再生. 它通过调节amid/sphingomyelin通路来促进血管生成,为骨缺陷提供治疗潜力.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 介酶干细胞 (MSC) 的分化对骨形成至关重要.
- 骨质生成和血管生成的结合对于骨的发育和修复至关重要.
研究的目的:
- 研究SGMS1在MSC骨质基因分化中的作用.
- 阐明SGMS1在骨质生成和血管生成合中的机制.
- 确定SGMS1作为骨缺陷的治疗点.
主要方法:
- 在实验室中研究了SGMS1对MSC骨质性分化的影响.
- 分析的胺 (Cer) 和髓 (SM) 含量.
- 评估了SGMS1对PP2A,Akt,Runx2和VEGF的影响.
- 在体内评估骨再生.
主要成果:
- 添加SGMS1加速了MSC骨质分化;沉默抑制了它.
- SGMS1调节了Cer/SM代谢,抑制了PP2A,并增加了酸化的Akt,Runx2和VEGF.
- SGMS1促进了MSC介导的血管生成,并在体内增强了骨再生.
结论:
- SGMS1诱导MSC骨质生成分化和骨质生成-血管生成合.
- 该机制涉及调节Cer/PP2A/Akt信号通路.
- SGMS1代表了骨发育不良和骨缺陷的潜在治疗标.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


